Can neonatal TSH screening reflect trends in population iodine intake?

Robert Burns1, Philip D Mayne, Colm O'Herlihy

  • 1UCD Conway Institute of Biomolecular and Biomedical Research, School of Medicine and Medical Science, University College Dublin, Dublin 4, Ireland.

Insights

Neonatal blood thyroid-stimulating hormone (TSH) levels in Ireland did not indicate severe iodine deficiency, but a subtle increase suggests potential future iodine insufficiency. Monitoring TSH trends is crucial for public health.

Area of Science:

  • Endocrinology
  • Neonatal Health
  • Public Health Nutrition

Background:

  • Neonatal blood TSH concentrations serve as an indicator of population iodine intake.
  • Ireland has observed a recent decrease in urinary iodine (UI) excretion among pregnant individuals.
  • This study investigates changes in neonatal TSH distribution in Ireland.

Purpose of the Study:

  • To determine if the percentage of neonatal blood TSH values > 5.0 mIU/L has changed.
  • To identify any emerging trends in neonatal blood TSH concentrations.
  • To assess the implications for iodine status in the Irish neonatal population.

Main Methods:

  • Analysis of neonatal blood samples from the National Neonatal Screening Programme (1995-2006).
  • Inclusion of samples from both winter (January) and summer (August) months to account for seasonal dietary variations.
  • Statistical analysis to evaluate trends in TSH values.

Main Results:

  • The proportion of neonatal blood TSH values > 5.0 mIU/L remained below 3% after 1995-1996, excluding severe iodine deficiency.
  • A significant declining trend in TSH values > 5.0 mIU/L was observed (p < 0.01).
  • A significant increasing trend in TSH within the 0-5.0 mIU/L range was detected between 1999-2006, particularly in summer (p < 0.001).

Conclusions:

  • The data suggest a link between fetal thyroid function and reduced maternal iodine intake.
  • While severe iodine deficiency is unlikely, the increasing TSH trend may signal early-stage iodine insufficiency.
  • These findings are relevant globally, given declining UI in many developed nations.
Abstract

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Redox Titration: Iodimetry and Iodometry01:23

Redox Titration: Iodimetry and Iodometry

Iodometry and iodimetry are analytical methods used to determine the concentration of oxidizing or reducing agents using iodine. In iodometric titrations, the oxidizing analyte solution is usually acidified and treated with an excess of iodide ions, which generates an equivalent amount of iodine in equilibrium with triiodide. The released iodine is subsequently titrated directly against a standardized reducing agent. As the dilute iodine color becomes pale yellow, a few drops of freshly...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...